Pancreatic ductal adenocarcinoma is a complex genetic disease, mainly determined by oncogenic activation of Kirsten rat sarcoma virus (KRAS) and mutations in tumor suppressor genes such Cyclin Dependent Kinase Inhibitor 2A (CDKN2A), Transformation Related Protein 53 (TP53), Lysine Demethylase 6A (KDM6A), Breast Cancer Gene (BRCA1/2), and SMAD Family Member 4 (SMAD4; Yachida and Iacobuzio-Donahue, 2009). This evidence concerns the gene KDM6A and pancreatic ductal adenocarcinoma.